Average Co-Inventor Count = 6.47
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pieris Pharmaceuticals Gmbh (7 from 36 patents)
2. Pieris Ag (4 from 16 patents)
3. Other (1 from 832,680 patents)
12 patents:
1. 11827681 - Muteins of human lipocalin 2 (Lcn2, hNGAL) with affinity for a given target
2. 10787491 - Nucleic acid molecules encoding muteins of human lipocalin 2 with affinity for glypican-3 (GPC3)
3. 10618941 - Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given target
4. 10526384 - Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof
5. 10273275 - Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof
6. 10046027 - Muteins of tear lipocalin and methods for obtaining the same
7. 9751920 - Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same
8. 9549968 - Muteins of human lipocalin 2 (LcnC,hNGAL) with affinity for a given target
9. 9221887 - Muteins of tear lipocalin and methods for obtaining the same
10. 9212208 - Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the same
11. 9051382 - Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such
12. 8313924 - Muteins of tear lipocalin and methods for obtaining the same